RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SANTORO D
Collezione ASL Vercelli

Items : 3

COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry in European Heart Journal - Quality of Care and Clinical Outcomes

2021
ASL Vercelli

De Luca L; Formigli D; Meessen J; Uguccioni M; Cosentino N; Paolillo C; Di Lenarda A; Colivicchi F; Gabrielli D; Gulizia MM; Scherillo M; Maras P; Ramani F; Falcone C; Passarelli I; Mauri S; Calabrò P; Bianchi R; Di Palma G; Mascia F; Vetrano A; Fusco A; Proia E; Aiello A; Tomai F; Licitra R; Petrolini A; Bosco B; Magliari F; et alii...

Effectiveness of Switch to Erythropoiesis-Stimulating Agent (ESA) Biosimilars versus Maintenance of ESA Originators in the Real-Life Setting: Matched-Control Study in Hemodialysis Patients. in Clinical drug investigation / Clin Drug Investig. 2017 Oct;37(10):965-973. doi: 10.1007/s40261-017-0562-8.

2017
ASL Vercelli

Minutolo R; Bolasco P; Chiodini P; Sposini S; Borzumati M; Abaterusso C; Mele AA; Santoro D; Canale V; Santoboni A; Filiberti O; Fiorini F; Mura C; Imperiali P; Borrelli S; Russo L; De Nicola L; Russo D;

Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients. in American journal of kidney diseases : the official journal of the National Kidney Foundation / Am J Kidney Dis. 2016 Jul;68(1):170-2. doi: 10.1053/j.ajkd.2016.01.011. Epub 2016 Feb 13.

2016
ASL Vercelli

Minutolo R; Borzumati M; Sposini S; Abaterusso C; Carraro G; Santoboni A; Mura C; Filiberti O; Santoro D; Musacchio R; Imperiali P; Fiorini F; De Nicola L; Russo D;